New oral medication shows promise for more quickly treating MRSA skin infections, researchers find

Share this article:

A new oral antibiotic may effectively treat MRSA-related skin infections more quickly than the only oral drug currently approved, according to research published Wednesday in the Journal of the American Medical Association.

Researchers led by Philippe Prokocimer, M.D., the chief medical officer at Trius Therapeutics Inc., compared the effectiveness of tedizolid phosphate with linezolid. Linezolid is the only oral medication currently approved to treat certain skin infections caused by methicillin-resistant Staphylococcus Aureus (MRSA).

The acute bacterial skin and skin structure infections (SSSIs) caused by MRSA can be fatal, and there have been outbreaks of linezolid-resistant strains of MRSA, the researchers noted.

In a 667-person trial carried out in North America, Latin America and Europe, participants received either a daily dose of tedizolid phosphate for six days or a dose of linezolid every 12 hours for 10 days.

Based on clinical outcomes, the researchers determined the newer drug is “clinically noninferior” to linezolid.

Nursing homes experience a high rate of community-associated MRSA, according to a study in the March issue of Infection Control and Hospital Epidemiology.

Share this article:
close

Next Article in News

More in News

Special surveys on dementia care, Minimum Data Set coding will launch by mid-year, CMS announces

Special surveys on dementia care, Minimum Data Set ...

Surveyors will scrutinize dementia care and Minimum Data Set coding in an upcoming pilot program to test more expansive oversight of these areas, the Centers for Medicare & Medicaid Services ...

Charges that Omnicare disguised nursing home kickbacks as charitable contributions can proceed, ...

A whistleblower can keep pursuing his allegations that long-term care pharmacy Omnicare funneled payments to nursing home owners through so-called charitable donations, U.S. District Court Judge Robert M. Dow Jr. recently ruled. Dow dismissed other charges leveled in the suit.

States can designate more nursing homes in urgent need of quality improvement, ...

The federal government is reactivating the special focus facility program for nursing homes with quality issues, the Centers for Medicare & Medicaid Services has announced. The program was minimized due to budget cuts last year.